AB

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark AB was filed as Figurative mark on 12/21/2020 at the World Intellectual Property Organization.

Logodesign (Wiener Klassifikation)

#Letters presenting a special form of writing #Monograms formed of intertwined, overlapping or otherwise combined letters

Trademark Details Last update: August 8, 2023

Trademark form Figurative mark
File reference 1585043
Countries Afghanistan Antigua and Barbuda Albania Armenia Australia Azerbaijan Bosnia and Herzegovina Bahrain Brunei Bhutan Botswana Belarus China Colombia Cuba Curacao Algeria Egypt Georgia Ghana Gambia Indonesia Israel India Iran Iceland Japan Kenya Kyrgyzstan Cambodia South Korea Kazakhstan Laos Liechtenstein Liberia Lesotho Morocco Monaco Moldova Montenegro Madagascar Macedonia Mongolia Malawi Mexico Malaysia Mozambique Namibia Norway New Zealand oa Oman Philippines Serbia Russia Rwanda Singapore Sierra Leone São Tomé and Príncipe Sint Maarten Syria Swaziland Thailand Tajikistan Turkmenistan Tunisia Turkey Ukraine Uzbekistan Vietnam Samoa Zambia Zimbabwe
Base trademark US No. 90018555, June 24, 2020
Application date December 21, 2020
Expiration date December 21, 2030

Trademark owner

1 West First Avenue
Conshohocken PA 19428
US

Trademark representatives

Kutak Rock LLP, 1650 Farnam St. US

goods and services

35 Wholesale distributorship services in the field of pharmaceuticals, medical and healthcare products; wholesale services connected with the sale of pharmaceutical, medical and healthcare products; wholesale distributorship services in the field of specialty pharmaceutical products, namely, disease specific pharmaceuticals; wholesale services connected with the sale of specialty pharmaceutical products, namely, disease specific pharmaceuticals; wholesale distributorship services featuring specialty healthcare products in the nature of pharmaceuticals and chemotherapeutics supplied in accordance with specially developed protocols to health-care providers and their patients; wholesale services connected with the sale of specialty healthcare products in the nature of pharmaceuticals and chemotherapeutics supplied in accordance with specially developed protocols to health-care providers and their patients; mail order retail services featuring pharmaceutical and biotechnological products; wholesale distributorship services in the field of animal health and veterinary products; wholesale distributorship services in the field of veterinary supplies featuring animal care and grooming products, animal nutritional supplements and medication; wholesale services connected with the sale of animal health and veterinary products; wholesale services connected with the sale of veterinary supplies featuring animal care and grooming products, animal nutritional supplements and medication; business consulting in the field of development and commercialization of biotechnological products; business consulting in the field of veterinary practice management; business consulting in the field of livestock management; business consulting services in the field of pharmaceuticals and other healthcare technologies, including the application of analytical and statistical methodology to the study of healthcare products and their impact on the overall healthcare market; advertising and marketing services in the field of healthcare products and services; cost containment in the field of healthcare providers and pharmacies relating to containing drug acquisition costs and recovering allowable reimbursement; business management consulting services in the field of pharmaceutical and healthcare products and services; business management consulting services in the field of pharmaceutical and healthcare product manufacturing, distribution, and logistics, namely, analyzing data about product inventory and sales, managing formularies, and marketing such products; healthcare business administration services in the healthcare field for pharmaceutical, biotechnology and medical device suppliers, namely, business consulting services in the cost and payment management of health care cost containment services, namely, providing expedited review, processing and follow-up of prior authorization requests initiated by physicians' offices and pharmacies, providing group purchasing of pharmaceuticals and chemotherapeutics for community-based providers including oncologists and oncology practices, business consulting services in the field of reimbursement for medical services rendered; conducting market research surveys in the field of healthcare costs and delivery cooperative advertising and marketing in the field of biotechnological products; providing information from an online non-downloadable database featuring information about consumer product sales at retail locations, about wholesale product sales to outlets, and about inventories of health-care products for use by commercial entities; retail pharmacy services featuring specialty pharmaceuticals and chemotherapeutics; temporary staffing for pharmacies, namely, providing, recruiting, retaining pharmacy personnel, and interim business managing of pharmacy operational and clinical functions; administration of a group purchasing and customer loyalty program for enabling participants to obtain unique benefits and perks in the nature of discounts on the costs of goods and services through use of a membership program to promote veterinary pharmaceuticals and services; providing business support staff services to manufacturers of pharmaceuticals; business management of customs brokers; administrative services, namely, tracking and monitoring import agency compliance for business purposes; administrative services relating to customs clearance
36 Financial management of reimbursement programs for healthcare providers and pharmacies relating to containing drug acquisition costs; providing counseling in the field of insurance coverage; customs brokerage; customs bonding, namely, issuance of importer bonds; processing of payment transactions relating to payment and return of customs duties
39 Courier services featuring storage, transport, and delivery of high-value, time-critical, ambient condition-sensitive, goods to professional and commercial users, namely, storage, transport, and delivery of investigational drugs, patient samples, and supplies used to conduct clinical trials, medicines and critical consumables for hospitals, clinics, research organizations, and physician practices, and critical parts and equipment for manufacturing, maintenance, and repair in the fields of aviation, automotive, oil and gas, and high tech; computerized tracking and tracing of documents, packages and freight in transit to ensure on-time delivery for business purposes

Trademark history

Date Document number Area Entry
June 20, 2023 2023/25 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
February 23, 2023 2023/8 Gaz JP Rejection
February 16, 2023 2023/8 Gaz TH Rejection
February 13, 2023 2023/8 Gaz IS Rejection
January 19, 2023 2023/4 Gaz UZ Rejection
January 19, 2023 2023/3 Gaz NO RAW: Rule 18ter(2)(ii) GP following a provisional refusal
October 5, 2022 2022/41 Gaz KR Rejection
September 30, 2022 2022/41 Gaz KH Rejection
September 20, 2022 2022/38 Gaz TM Rejection
September 12, 2022 2022/38 Gaz IS Rejection
July 4, 2022 2022/27 Gaz MX Rejection
June 30, 2022 2022/27 Gaz MD Rejection
June 15, 2022 2022/25 Gaz KR Rejection
June 5, 2022 2022/23 Gaz WS Rejection
May 30, 2022 2022/22 Gaz LA Rejection
May 27, 2022 2022/22 Gaz BA Rejection
April 16, 2022 2022/17 Gaz UZ Rejection
April 7, 2022 2022/14 Gaz VN Rejection
April 1, 2022 2022/14 Gaz LI Rejection
March 31, 2022 2022/14 Gaz AL Rejection
March 25, 2022 2022/13 Gaz NZ RAW: Rule 18ter(2)(ii) GP following a provisional refusal
March 17, 2022 2022/13 Gaz JP Rejection
March 16, 2022 2022/12 Gaz MD Rejection
March 15, 2022 2022/13 Gaz OA Rejection
March 11, 2022 2022/13 Gaz GE Rejection
March 11, 2022 2022/13 Gaz AM Rejection
February 25, 2022 2022/12 Gaz ME Rejection
February 16, 2022 2022/8 Gaz MY Rejection
February 15, 2022 2022/7 Gaz BW Rejection
February 8, 2022 2022/6 Gaz TJ Rejection
February 8, 2022 2022/6 Gaz CU Rejection
February 3, 2022 2022/5 Gaz UA Rejection
January 7, 2022 2022/4 Gaz SX Rejection
January 1, 2022 2022/3 Gaz CO Rejection
December 30, 2021 2022/5 Gaz MN RAW: Rule 18ter(2)(i) GP following a provisional refusal
December 28, 2021 2022/2 Gaz KG Rejection
December 22, 2021 2022/1 Gaz KZ Rejection
December 10, 2021 2021/50 Gaz NO Rejection
December 5, 2021 2021/50 Gaz IL Rejection
November 18, 2021 2021/49 Gaz CW Rejection
November 17, 2021 2021/48 Gaz MC Rejection
November 16, 2021 2021/48 Gaz DZ Rejection
November 15, 2021 2021/46 Gaz TR Rejection
November 10, 2021 2021/46 Gaz BY Rejection
October 31, 2021 2021/45 Gaz SY Rejection
October 15, 2021 2021/45 Gaz MG Rejection
October 8, 2021 2021/43 Gaz BT Rejection
September 6, 2021 2021/43 Gaz RS Rejection
August 31, 2021 2021/36 Gaz MN Rejection
August 30, 2021 2021/38 Gaz CN Rejection
July 30, 2021 2021/31 Gaz NZ Rejection
June 28, 2021 2021/27 Gaz RU Rejection
June 23, 2021 2021/26 Gaz AU Rejection
May 26, 2021 2021/22 Gaz SG Rejection
May 3, 2021 2021/19 Gaz IN Rejection
April 21, 2021 2021/17 Gaz PH Rejection
April 20, 2021 2021/17 Gaz IR Rejection
December 21, 2020 2021/12 Gaz US Registration

ID: 141585043